drugset / Trial / NCT02041650

Paradigm Shift in the Treatment of Patients With ACS

NCT02041650 ↗

Phase 4 Completed 250 enrolled Yu Bo Massachusetts General Hospital · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This protocol describes a pilot study intended to test the hypothesis that patients with acute coronary syndrome (ACS) caused by plaque erosion can be stabilized by effective antithrombotic treatment without stent implantation, thereby avoiding both early and late complications related to percutaneous coronary intervention (PCI).

Timeline

Start
2014-08
Primary completion
2016-04
Completion
2017-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ticagrelor Small molecule — —